These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34373363)

  • 1. Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year.
    Jo IH; Lee KM; Kim DB; Kim JW; Lee J; Jeen YT; Kim TO; Kim JS; Park JJ; Hong SN; Park DI; Kim HS; Lee YJ; Kim Y
    Gut Liver; 2022 May; 16(3):384-395. PubMed ID: 34373363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea.
    Moon JR; Lee CK; Hong SN; Im JP; Ye BD; Cha JM; Jung SA; Lee KM; Park DI; Jeen YT; Park YS; Cheon JH; Kim H; Seo B; Kim Y; Kim HJ;
    Gut Liver; 2020 Jul; 14(4):459-467. PubMed ID: 31533398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months.
    Teich N; Grümmer H; Jörgensen E; Liceni T; Holtkamp-Endemann F; Fischer T; Hohenberger S
    BMC Gastroenterol; 2021 Apr; 21(1):161. PubMed ID: 33845784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK).
    Yoon JY; Cha JM; Lee CK; Park YS; Huh KC; Shin JE; Kim YS; Eun CS; Yoon SM; Cheon JH; Park YS; Ye BD; Lee Y; Kim Y; Kim HJ;
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2149-2156. PubMed ID: 33555067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain.
    Targownik L; Dubinsky MC; Steinwurz F; Bushmakin AG; Cappelleri JC; Tai E; Gardiner S; Hur P; Panés J
    J Crohns Colitis; 2023 Apr; 17(4):513-523. PubMed ID: 36271912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis.
    Zheng K; Zhang S; Wang C; Zhao W; Shen H
    PLoS One; 2015; 10(4):e0124211. PubMed ID: 25915777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program.
    Dubinsky MC; Armuzzi A; Gecse KB; Ullman T; Bushmakin AG; DiBonaventura M; Cappelleri JC; Connelly SB; Woolcott JC; Salese L
    Dig Dis; 2023; 41(4):604-614. PubMed ID: 36603566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
    Feagan BG; Patel H; Colombel JF; Rubin DT; James A; Mody R; Lasch K
    Aliment Pharmacol Ther; 2017 Jan; 45(2):264-275. PubMed ID: 27859410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.
    Paschos P; Katsoula A; Salanti G; Giouleme O; Athanasiadou E; Tsapas A
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1174-1185. PubMed ID: 30378141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.
    Armuzzi A; Rubin DT; Schreiber S; Panés J; Fellmann M; Bartolome L; Gruben D; Goetsch M; Bhattacharjee A; Chaparro M; Dubinsky MC
    Inflamm Bowel Dis; 2024 Sep; ():. PubMed ID: 39326009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortened questionnaire on quality of life for inflammatory bowel disease.
    Alcalá MJ; Casellas F; Fontanet G; Prieto L; Malagelada JR
    Inflamm Bowel Dis; 2004 Jul; 10(4):383-91. PubMed ID: 15475746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy.
    Malik BA; Gibbons K; Spady D; Lees G; Otley A; Huynh HQ
    Int J Colorectal Dis; 2013 Mar; 28(3):325-33. PubMed ID: 22914964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
    Feagan BG; Reinisch W; Rutgeerts P; Sandborn WJ; Yan S; Eisenberg D; Bala M; Johanns J; Olson A; Hanauer SB
    Am J Gastroenterol; 2007 Apr; 102(4):794-802. PubMed ID: 17324131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.
    Solomon D; Yarlas A; Hodgkins P; Karlstadt R; Yen L; Kane S
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1386-96. PubMed ID: 22536781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.
    Gibson PR; Vaizey C; Black CM; Nicholls R; Weston AR; Bampton P; Sparrow M; Lawrance IC; Selby WS; Andrews JM; Walsh AJ; Hetzel DJ; Macrae FA; Moore GT; Weltman MD; Leong RW; Fan T
    J Crohns Colitis; 2014 Jul; 8(7):598-606. PubMed ID: 24345767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease(IBDQ-32)].
    Masachs M; Casellas F; Malagelada JR
    Rev Esp Enferm Dig; 2007 Sep; 99(9):511-9. PubMed ID: 18052646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
    Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
    Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Yarlas A; D'Haens G; Willian MK; Teynor M
    Inflamm Bowel Dis; 2018 Jan; 24(2):450-463. PubMed ID: 29361097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease.
    Ren WH; Lai M; Chen Y; Irvine EJ; Zhou YX
    Inflamm Bowel Dis; 2007 Jul; 13(7):903-10. PubMed ID: 17309070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.